May 31, 2022 / 05:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the NATCO Pharma Q4 FY '22 Conference Call, hosted by Edelweiss Securities Limited. (Operator Instructions) I now hand the conference over to Mr. Kunal Randeria from Edelweiss Securities Limited. Thank you, and over to you, sir.
Kunal Randeria - Edelweiss Securities Limited, Research Division - Research Analyst
Thank you, Diksha, and good morning, everyone. On behalf of Edelweiss Securities, I welcome you all for NATCO Pharma's Q4 FY '22 Earnings Call. With us, we have NATCO Pharma's senior management, represented by Mr. Rajeev Nannapaneni, Director and Chief Executive Officer; and Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences. So over to you, Rajesh for opening remarks.
Rajesh Chebiyam - NATCO Pharma Limited - EVP of Crop Health Sciences
Right. Thank you, Kunal. Good morning, and welcome, everyone, to NATCO's conference call, discussing our earnings results for the fourth quarter of FY '22 and for the full year, which ended March 31, 2022.
Q4 2022 Natco Pharma Ltd Earnings Call Transcript
May 31, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers